Comprehensive Financial Management’s Eikon Therapeutics EIKN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.13M Buy
140,856
+24,580
+21% +$247K 0.04% 32
2026
Q2
$1.52M Hold
116,276
– – 0.05% 26
2026
Q1
$1.23M Buy
+116,276
New +$1.55M 0.04% 28

Other funds holding EIKN

Comprehensive Financial Management's EIKN Position: Q3 2026 in Review

Comprehensive Financial Management increased its Eikon Therapeutics (EIKN) stake by 21% in Q3 2026, buying an estimated $247K and bringing the position to 140,856 shares worth $1.13M. The position accounts for 0.04% of the portfolio, ranked #32.

Comprehensive Financial Management first reported a position in EIKN in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.52M in Q2 2026. 98 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.

  • Comprehensive Financial Management held 140,856 shares of Eikon Therapeutics worth $1.13M as of Q3 2026.
  • Comprehensive Financial Management bought 24,580 Eikon Therapeutics shares in Q3 2026, an estimated $247K.
  • Eikon Therapeutics made up 0.04% of Comprehensive Financial Management's portfolio in Q3 2026, its #32 holding.
  • Comprehensive Financial Management first reported a position in Eikon Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Comprehensive Financial Management's Eikon Therapeutics position peaked at $1.52M in Q2 2026.
  • 98 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.

Based on Comprehensive Financial Management's 13F filing for Q3 2026, filed 16 Nov 2026.